PL145103B1 - Method of obtaining novel concentrated two-ring derivatives of imidazole - Google Patents

Method of obtaining novel concentrated two-ring derivatives of imidazole Download PDF

Info

Publication number
PL145103B1
PL145103B1 PL1985259303A PL25930385A PL145103B1 PL 145103 B1 PL145103 B1 PL 145103B1 PL 1985259303 A PL1985259303 A PL 1985259303A PL 25930385 A PL25930385 A PL 25930385A PL 145103 B1 PL145103 B1 PL 145103B1
Authority
PL
Poland
Prior art keywords
compounds
formula
alkyl
salts
tetrahydroimidazo
Prior art date
Application number
PL1985259303A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL145103B1 publication Critical patent/PL145103B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL1985259303A 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole PL145103B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/622,421 US4617307A (en) 1984-06-20 1984-06-20 Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors

Publications (1)

Publication Number Publication Date
PL145103B1 true PL145103B1 (en) 1988-08-31

Family

ID=24494112

Family Applications (6)

Application Number Title Priority Date Filing Date
PL1985259303A PL145103B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259305A PL145814B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed derivatives of double-ring imidazole
PL1985259304A PL145348B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed disubstituted imidazole derivatives
PL1985254099A PL145087B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel derivatives of imidazo /1,5-a/ pyridine
PL1985259307A PL145105B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259306A PL145104B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole

Family Applications After (5)

Application Number Title Priority Date Filing Date
PL1985259305A PL145814B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed derivatives of double-ring imidazole
PL1985259304A PL145348B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel condensed disubstituted imidazole derivatives
PL1985254099A PL145087B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel derivatives of imidazo /1,5-a/ pyridine
PL1985259307A PL145105B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole
PL1985259306A PL145104B1 (en) 1984-06-20 1985-06-20 Method of obtaining novel concentrated two-ring derivatives of imidazole

Country Status (31)

Country Link
US (1) US4617307A (forum.php)
EP (1) EP0165904B1 (forum.php)
JP (1) JPS6112688A (forum.php)
KR (1) KR900008566B1 (forum.php)
AT (1) ATE62415T1 (forum.php)
AU (1) AU589565B2 (forum.php)
BG (7) BG60262B2 (forum.php)
CA (1) CA1276633C (forum.php)
CS (1) CS268672B2 (forum.php)
CY (1) CY1750A (forum.php)
DD (1) DD237510A5 (forum.php)
DE (1) DE3582452D1 (forum.php)
DK (1) DK170302B1 (forum.php)
DZ (1) DZ799A1 (forum.php)
ES (6) ES8702406A1 (forum.php)
FI (1) FI80694C (forum.php)
GR (1) GR851487B (forum.php)
HK (1) HK23494A (forum.php)
HU (1) HU202529B (forum.php)
IE (1) IE58070B1 (forum.php)
IL (1) IL75546A (forum.php)
MA (1) MA20459A1 (forum.php)
MX (1) MX9203369A (forum.php)
NO (1) NO162467C (forum.php)
NZ (1) NZ212483A (forum.php)
PH (1) PH23390A (forum.php)
PL (6) PL145103B1 (forum.php)
PT (1) PT80661B (forum.php)
RO (1) RO92583A (forum.php)
SU (6) SU1433413A3 (forum.php)
ZA (1) ZA854615B (forum.php)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US5428160A (en) * 1982-12-21 1995-06-27 Ciba-Geigy Corporation Substituted imidazo[5-a]pyridine derviatives and other substituted bicyclic derivatives
US4889861A (en) * 1982-12-21 1989-12-26 Ciba-Geigy Corp. Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
GB8510541D0 (en) * 1985-04-25 1985-05-30 Wyeth John & Brother Ltd Heterocyclic compounds
US5171858A (en) * 1985-06-05 1992-12-15 Schering A.G. Preparation of certain 5,6-dihydro-8-phenyl-imidazo[1,5-a]pyridines
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4797411A (en) * 1986-07-18 1989-01-10 Farmitalia Carlo Erba S.P.A. Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors
GB8820730D0 (en) * 1988-09-02 1988-10-05 Erba Carlo Spa Substituted 5 6 7 8-tetrahydroimidazo/1.5-a/pyridines & process for their preparation
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
EP0514015A1 (en) * 1991-04-19 1992-11-19 Merck & Co. Inc. Control of sex differentiation in fish
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
JPH05176659A (ja) * 1991-04-26 1993-07-20 Merck & Co Inc 家禽における雌性表現型を転換するために抗ミュラー管ホルモンを単独またはアロマターゼ阻害剤と組合せて使用する方法
AU2356195A (en) * 1994-04-14 1995-11-10 Sepracor, Inc. Treating estrogen-dependent diseases with (-)-fadrozole
EP0684235A1 (en) * 1994-05-27 1995-11-29 Mochida Pharmaceutical Co., Ltd. Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
DE4432106A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
AU2003250190A1 (en) * 2002-07-30 2004-02-23 Novartis Ag Combination of an aromatase inhibitor with a bisphosphonate
ATE335744T1 (de) * 2002-08-07 2006-09-15 Novartis Pharma Gmbh Organische verbindungen als mittel zur behandlung von aldosteronbedingten zuständen
AU2003292039A1 (en) * 2002-11-18 2004-06-15 Novartis Ag Imidazo(1, 5a)pyridine derivatives and methods for treating aldosterone mediated diseases
WO2005007627A1 (ja) * 2003-07-18 2005-01-27 Nihon Nohyaku Co., Ltd. フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
EP1977741A3 (en) 2004-03-17 2009-10-14 Novartis AG Use of renin inhibitors in therapy
CA2568159A1 (en) * 2004-05-28 2005-12-15 Speedel Experimenta Ag Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors
JP2008500998A (ja) * 2004-05-28 2008-01-17 シュペーデル・エクスペリメンタ・アーゲー 複素環式化合物およびアルドステロンシンターゼ阻害薬としてのそれらの使用
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
EP1842543A1 (en) 2006-04-05 2007-10-10 Speedel Pharma AG Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
MX2008015008A (es) * 2006-05-26 2008-12-05 Novartis Ag INHIBIDORES DE SINTASA DE ALDOSTERONA Y/O DE 11ß-HIDROXILASA.
CA2657258A1 (en) 2006-07-20 2008-01-24 Novartis Ag Amino-piperidine derivatives as cetp inhibitors
JP2010501573A (ja) * 2006-08-25 2010-01-21 ノバルティス アクチエンゲゼルシャフト アルドステロン合成酵素および／または１１−β−ヒドロキシラーゼおよび／またはアロマターゼが介在する疾患の処置のための縮合イミダゾール誘導体
US20090325936A1 (en) * 2006-12-20 2009-12-31 Bilodeau Mark T Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
PT2207775E (pt) 2007-11-05 2012-05-11 Novartis Ag Derivados de 4-benzilamino-1-carboxiacil-piperidina como inibidores de cetp úteis para o tratamento de doenças tais como hiperlipidemia ou arteriosclerose
ES2375527T3 (es) 2007-12-03 2012-03-01 Novartis Ag Derivados 1,2-disustituidos-4-bencilamino-pirrolidina como inhibidores cetp útiles para el tratamiento de enfermedades tales como hiperlipidemia o arteriosclerosis.
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
MX2011012628A (es) 2009-05-28 2011-12-14 Novartis Ag Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
EP3048100A1 (en) 2009-05-28 2016-07-27 Novartis AG Substituted aminobutyric derivatives as neprilysin inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
AR086665A1 (es) 2011-06-14 2014-01-15 Lilly Co Eli Inhibidor de aldosterona sintasa y composiciones farmaceuticas
PT2729142T (pt) 2011-07-08 2018-10-01 Novartis Ag Método de tratamento de aterosclerose em sujeitos com nível elevado de triglicéridos
TWI609869B (zh) 2012-01-17 2018-01-01 諾華公司 二氫吡咯并［１，２－ｃ］咪唑基皮質醛酮素合成酶或芳族酶抑制劑之新穎型式及鹽
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
NZ710574A (en) 2013-02-14 2017-11-24 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
AP2016009019A0 (en) 2013-07-25 2016-02-29 Novartis Ag Bioconjugates of synthetic apelin polypeptides
SG11201600211XA (en) 2013-07-25 2016-02-26 Novartis Ag Cyclic polypeptides for the treatment of heart failure
CN107406490A (zh) 2015-01-23 2017-11-28 诺华股份有限公司 具有改善的半衰期的合成apelin脂肪酸缀合物
CN107207518B (zh) * 2015-01-29 2021-03-30 雷科尔达蒂股份公司 生产稠合咪唑衍生物的工艺
GB201511790D0 (en) 2015-07-06 2015-08-19 Iomet Pharma Ltd Pharmaceutical compound
JP2016074729A (ja) * 2015-12-31 2016-05-12 国立大学法人 千葉大学 イミダゾリウム塩及びそれを用いた不斉合成触媒並びにイミダゾリウム塩の製造方法
JOP20190086A1 (ar) 2016-10-21 2019-04-18 Novartis Ag مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
WO2018078049A1 (en) 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
US10822332B2 (en) * 2016-10-27 2020-11-03 Damian Pharma Ag Aldosterone synthase inhibitor
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
JP7470050B2 (ja) 2018-05-03 2024-04-17 ダミアン ファーマ アーゲー アルドステロン症の治療における使用のためのｒ－ファドロゾール
UY38485A (es) 2018-11-27 2020-06-30 Novartis Ag Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
JP2022507958A (ja) 2018-11-27 2022-01-18 ノバルティス アーゲー 代謝障害の治療用のプロタンパク質転換酵素サブチリシン／ケキシン９型（ｐｃｓｋ９）阻害薬としての環状四量体化合物
WO2020110011A1 (en) 2018-11-27 2020-06-04 Novartis Ag Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorders
WO2023084449A1 (en) 2021-11-12 2023-05-19 Novartis Ag Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5124517B1 (forum.php) * 1971-03-15 1976-07-24
FR2449689A1 (fr) * 1979-02-20 1980-09-19 Logeais Labor Jacques Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
CA1250844A (en) * 1981-06-22 1989-03-07 Neville Ford Substituted imidazo¬1,5-a|pyridines, process for their manufacture, pharmaceutical preparations containing these compounds and their therapeutic application
US4409226A (en) * 1981-10-05 1983-10-11 Schering Corporation Imidazo[1,5-a]pyridines
US4361567A (en) * 1981-10-05 1982-11-30 Schering Corporation Treatment of peptic ulcer disease
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors

Also Published As

Publication number Publication date
PL145348B1 (en) 1988-09-30
SU1482530A3 (ru) 1989-05-23
KR860000299A (ko) 1986-01-27
NZ212483A (en) 1988-10-28
BG60306B2 (bg) 1994-07-25
SU1436880A3 (ru) 1988-11-07
HK23494A (en) 1994-03-25
IE851520L (en) 1985-12-20
BG60353B2 (bg) 1994-11-30
ES555542A0 (es) 1988-03-16
DK170302B1 (da) 1995-07-31
EP0165904A2 (de) 1985-12-27
DD237510A5 (de) 1986-07-16
PT80661B (en) 1987-05-04
FI852399A0 (fi) 1985-06-17
PL145105B1 (en) 1988-08-31
KR900008566B1 (ko) 1990-11-24
BG60305B2 (bg) 1994-07-25
BG60402B2 (bg) 1995-02-28
ES555539A0 (es) 1988-04-01
ES555538A0 (es) 1988-03-16
SU1443802A3 (ru) 1988-12-07
SU1436879A3 (ru) 1988-11-07
SU1433413A3 (ru) 1988-10-23
ATE62415T1 (de) 1991-04-15
DZ799A1 (fr) 2004-09-13
AU4385785A (en) 1986-01-02
PH23390A (en) 1989-07-26
BG60352B2 (bg) 1994-11-30
HU202529B (en) 1991-03-28
PL254099A1 (en) 1986-09-09
GR851487B (forum.php) 1985-11-25
JPS6112688A (ja) 1986-01-21
RO92583A (ro) 1987-11-30
ES8802049A1 (es) 1988-03-16
ZA854615B (en) 1986-02-26
FI80694B (fi) 1990-03-30
CY1750A (en) 1994-06-03
NO852474L (no) 1985-12-23
DK277685A (da) 1985-12-21
AU589565B2 (en) 1989-10-19
SU1436878A3 (ru) 1988-11-07
PL145104B1 (en) 1988-08-31
CS444985A2 (en) 1989-07-12
PL145087B1 (en) 1988-08-31
FI80694C (fi) 1990-07-10
BG60307B2 (en) 1994-07-25
NO162467B (no) 1989-09-25
US4617307A (en) 1986-10-14
CA1276633C (en) 1990-11-20
HUT37936A (en) 1986-03-28
ES8802155A1 (es) 1988-04-01
ES555540A0 (es) 1987-12-16
JPH047746B2 (forum.php) 1992-02-12
BG60262B1 (bg) 1994-03-31
BG60262B2 (en) 1994-03-31
IL75546A (en) 1990-01-18
PT80661A (en) 1985-07-01
NO162467C (no) 1990-01-10
PL145814B1 (en) 1988-11-30
ES8802048A1 (es) 1988-03-16
IL75546A0 (en) 1985-10-31
EP0165904B1 (de) 1991-04-10
FI852399L (fi) 1985-12-21
MA20459A1 (fr) 1985-12-31
IE58070B1 (en) 1993-06-30
ES8800681A1 (es) 1987-11-16
DE3582452D1 (de) 1991-05-16
ES544344A0 (es) 1987-01-01
MX9203369A (es) 1992-09-01
CS268672B2 (en) 1990-04-11
ES8801262A1 (es) 1987-12-16
EP0165904A3 (en) 1987-09-09
DK277685D0 (da) 1985-06-19
ES555541A0 (es) 1987-11-16
ES8702406A1 (es) 1987-01-01

Similar Documents

Publication Publication Date Title
PL145103B1 (en) Method of obtaining novel concentrated two-ring derivatives of imidazole
US5364847A (en) Inhibitors of sex steroid biosynthesis and methods for their production and use
EP2499151A2 (en) Mammalian metabolites of steroids
IE904704A1 (en) Novel ß-carbolines, processes for their preparation and¹their use in medicaments
EP3564242B1 (en) Compound for selectively inhibiting kinase and use thereof
HU186107B (en) Process for preparing imidazo-tetrazine derivatives
US5476933A (en) Azepine synthesis via a diels-alder reaction
US20080214570A1 (en) Therapeutic Agents
US4434171A (en) Dibenzazepine derivatives, pharmaceutical compositions containing them, and pharmaceutical methods using them
EP2617720A1 (en) Novel cortistatin a analog and use thereof
HUT54151A (en) Process fopr producing new (r)-(-)-3-quinuclidinone derivatives and pharmaceutical compositions comprising such compounds
EP0161102B1 (en) Isoquinoline derivatives
KR900005278B1 (ko) 치환된 디벤조디아제피논의 제조방법
US5428160A (en) Substituted imidazo[5-a]pyridine derviatives and other substituted bicyclic derivatives
US5929087A (en) Decahydroquinoline-based anti-cholinergic agents
JP3999275B2 (ja) グルタミン酸輸送体阻害作用を有するジテルベン化合物
CS268686B2 (en) Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
NL8800099A (nl) Pilocarpinederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
HU189572B (en) Process for producing 6-substituted hexahydro-indazol-isoquinolines
FR2640975A1 (forum.php)
CS268684B2 (en) Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
NZ207458A (en) Pyridylaminoethene derivatives and pharmaceutical compositions
GB2136429A (en) Aminoethenes
ITMI940202A1 (it) Derivati di idroisochinolina